These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 29291394

  • 21. Transesophageal echocardiographic assessment of the contribution of intrinsic tissue thickness to the appearance of a thick mitral valve in patients with mitral valve prolapse.
    Louie EK, Langholz D, Mackin WJ, Wallis DE, Jacobs WR, Scanlon PJ.
    J Am Coll Cardiol; 1996 Aug; 28(2):465-71. PubMed ID: 8800127
    [Abstract] [Full Text] [Related]

  • 22. Unravelling the proteome of degenerative human mitral valves.
    Tan HT, Lim TK, Richards AM, Kofidis T, Teoh KL, Ling LH, Chung MC.
    Proteomics; 2015 Sep; 15(17):2934-44. PubMed ID: 25914152
    [Abstract] [Full Text] [Related]

  • 23. Spectrum of structural abnormalities in floppy mitral valve echocardiographic evaluation.
    Malkowski MJ, Boudoulas H, Wooley CF, Guo R, Pearson AC, Gray PG.
    Am Heart J; 1996 Jul; 132(1 Pt 1):145-51. PubMed ID: 8701857
    [Abstract] [Full Text] [Related]

  • 24. Function and expression differences between ergot and non-ergot dopamine D2 agonists on heart valve interstitial cells.
    Oana F, Onozuka H, Tsuchioka A, Suzuki T, Tanaka N, Kaidoh K, Hoyano Y, Hiratochi M, Kikuchi S, Takehana Y, Shibata N.
    J Heart Valve Dis; 2014 Mar; 23(2):246-52. PubMed ID: 25076559
    [Abstract] [Full Text] [Related]

  • 25. [The prevalence and clinical features of pathologically abnormal mitral valve leaflets (myxomatous mitral valve) in the mitral valve prolapse syndrome: an echocardiographic and pathological comparative study].
    Takamoto T, Nitta M, Tsujibayashi T, Taniguchi K, Marumo F.
    J Cardiol Suppl; 1991 Mar; 25():75-86. PubMed ID: 1888468
    [Abstract] [Full Text] [Related]

  • 26. The morphologic characteristics of flail mitral leaflets by transesophageal echocardiography.
    Malkowski MJ, Guo R, Orsinelli DA, Wooley CF, Tice FD, Pearson AC, Boudoulas H.
    J Heart Valve Dis; 1997 Jan; 6(1):54-9. PubMed ID: 9044077
    [Abstract] [Full Text] [Related]

  • 27. Tenascin C promotes valvular remodeling in two large animal models of ischemic mitral regurgitation.
    Hamza O, Kiss A, Kramer AM, Trojanek S, Abraham D, Acar E, Nagel F, Tretter VE, Kitzwögerer M, Podesser BK.
    Basic Res Cardiol; 2020 Dec 01; 115(6):76. PubMed ID: 33258993
    [Abstract] [Full Text] [Related]

  • 28. On the role of predicted in vivo mitral valve interstitial cell deformation on its biosynthetic behavior.
    Ayoub S, Howsmon DP, Lee CH, Sacks MS.
    Biomech Model Mechanobiol; 2021 Feb 01; 20(1):135-144. PubMed ID: 32761471
    [Abstract] [Full Text] [Related]

  • 29. Insights into malignant mitral valve degenerative disease from a sudden cardiac death cohort highlighting significant measurement differences from normal.
    Westaby J, Bicalho L, Zullo E, Sheppard MN.
    Histopathology; 2024 May 01; 84(6):960-966. PubMed ID: 38233105
    [Abstract] [Full Text] [Related]

  • 30. Frequency and significance of M-mode echocardiographic evidence of mitral valve prolapse in clinically isolated pure mitral regurgitation: analysis of 65 patients having mitral valve replacement.
    Waller BF, Maron BJ, Del Negro AA, Gottdiener JS, Roberts WC.
    Am J Cardiol; 1984 Jan 01; 53(1):139-47. PubMed ID: 6691250
    [Abstract] [Full Text] [Related]

  • 31. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S, Orton EC.
    J Heart Valve Dis; 2009 Jan 01; 18(1):44-51. PubMed ID: 19301552
    [Abstract] [Full Text] [Related]

  • 32. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.
    Xu N, Alfieri CM, Yu Y, Guo M, Yutzey KE.
    Arterioscler Thromb Vasc Biol; 2024 Jul 01; 44(7):1540-1554. PubMed ID: 38660802
    [Abstract] [Full Text] [Related]

  • 33. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition.
    Songia P, Branchetti E, Parolari A, Myasoedova V, Ferrari G, Alamanni F, Tremoli E, Poggio P.
    J Mol Cell Cardiol; 2016 Sep 01; 98():48-57. PubMed ID: 27338002
    [Abstract] [Full Text] [Related]

  • 34. The effects of mitral regurgitation alone are sufficient for leaflet remodeling.
    Stephens EH, Nguyen TC, Itoh A, Ingels NB, Miller DC, Grande-Allen KJ.
    Circulation; 2008 Sep 30; 118(14 Suppl):S243-9. PubMed ID: 18824762
    [Abstract] [Full Text] [Related]

  • 35. Causes of repair failure for degenerative mitral valve disease and reoperation outcomes.
    Nishida H, Fukui T, Kasegawa H, Kin H, Yamazaki M, Takanashi S.
    Eur J Cardiothorac Surg; 2018 Jun 01; 53(6):1244-1250. PubMed ID: 29309559
    [Abstract] [Full Text] [Related]

  • 36. 5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.
    Nelson PM, Harrod JS, Lamping KG.
    Exp Diabetes Res; 2012 Jun 01; 2012():398406. PubMed ID: 23346101
    [Abstract] [Full Text] [Related]

  • 37. Modeling Impaired Coaptation Effects on Mitral Leaflet Homeostasis Using a Flow-Culture Bioreactor.
    Maeda K, Ma X, Hanley FL, Riemer RK.
    Ann Thorac Surg; 2019 Feb 01; 107(2):512-518. PubMed ID: 30365966
    [Abstract] [Full Text] [Related]

  • 38. Serotonin transporter deficiency in mice results in an increased susceptibility to HTR2B-dependent pro-fibrotic mechanisms in the cardiac valves and left ventricular myocardium.
    Castillero E, Camillo C, Levine D, D'Angelo AM, Kosuri Y, Grau JB, Levy RJ, Ferrari G.
    Cardiovasc Pathol; 2025 Feb 01; 74():107689. PubMed ID: 39245153
    [Abstract] [Full Text] [Related]

  • 39. Gross and histological features of excised portions of posterior mitral leaflet in patients having operative repair of mitral valve prolapse and comments on the concept of missing (= ruptured) chordae tendineae.
    Roberts WC, Vowels TJ, Ko JM, Hebeler RF.
    J Am Coll Cardiol; 2014 Apr 29; 63(16):1667-74. PubMed ID: 24316086
    [Abstract] [Full Text] [Related]

  • 40. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
    Arndt JW, Reynolds CA, Singletary GE, Connolly JM, Levy RJ, Oyama MA.
    J Vet Intern Med; 2009 Apr 29; 23(6):1208-13. PubMed ID: 19709352
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.